title: Attack, parry and riposte: molecular fencing between the innate immune system and human herpesviruses.
abstract: Once individuals acquire one of the eight human-pathogenic herpesviruses, the upcoming relationship is predefined to last lifelong. Despite the fact that acute phases of herpesviral replication are usually confined and controlled by a concerted action of all branches of the healthy immune system, sterile immunity is never reached. To accomplish this, herpesviruses evolved the unique ability to outlast episodes of efficient immunity in a dormant state called latency and a remarkable array of immune antagonists which counteract most (if not all) relevant aspects of intrinsic, innate and adaptive immune responses. Certain psychological and physiological conditions (such as stress, immuno-suppression or pregnancy) predispose for viral reactivation which can lead to recurrent disease and virus spread. One important pillar of immunity is the innate immune system. The leading cytokines of the innate immune response are interferons (IFN). IFNs reinforce intrinsic immunity, induce a cell-intrinsic antiviral state and recruit and orchestrate adaptive immunity. Consistently, individuals lacking a functional IFN system suffer from otherwise harmless opportunists and live-attenuated vaccines. The selective pressure elicited by IFNs drove herpesviruses to evolve numerous IFN antagonistic gene products. A molecular in-depth understanding of (herpes-) viral IFN antagonists might allow the design of novel antiviral drugs which reconstitute IFN responses by blocking the antagonistic function and thereby help the host to help himself. Additionally, virus mutants lacking immune evasins constitute promising candidates for vaccine viruses. Here we summarize the current knowledge on IFN antagonistic strategies of the eight human herpesviruses and try to decipher common strategies.
authors.affiliation: Institute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
authors.forename: V T K
authors.initials: VT
authors.lastname: Le-Trilling
authors.affiliation: Institute for Virology, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
authors.forename: M
authors.initials: M
authors.lastname: Trilling
mesh_terms: D056704:Adaptive Immunity; D005786:Gene Expression Regulation; D006564:Herpesviridae / Q000276:immunology* / Q000472:pathogenicity; D006566:Herpesviridae Infections / Q000276:immunology / Q000473:pathology / Q000821:virology*; D006801:Humans; D057131:Immune Evasion; D007113:Immunity, Innate; D007372:Interferons / Q000037:antagonists & inhibitors* / Q000235:genetics / Q000276:immunology; D050794:STAT1 Transcription Factor / Q000235:genetics / Q000276:immunology; D050795:STAT2 Transcription Factor / Q000235:genetics / Q000276:immunology; D015398:Signal Transduction; D014452:Ubiquitins / Q000235:genetics / Q000276:immunology; D014764:Viral Proteins / Q000235:genetics* / Q000276:immunology
chemical_list: D050794:STAT1 Transcription Factor; C494079:STAT1 protein, human; D050795:STAT2 Transcription Factor; C494084:STAT2 protein, human; D014452:Ubiquitins; D014764:Viral Proteins; D007372:Interferons
keywords: antiviral; herpes virus; immune evasion; innate immunity; interferon